Breast Cancer Research · 2017 · 88 citations · 25 references
MedicineNeuroscienceOncologyCell SignalingMetastasisTumor MicroenvironmentBrain MetastasesBrain MetastasisBrain TumorsCancer Cell SignalingMetastatic ColonizationMetastatic Signaling PathwaysBrain ColonizationBrain Metastatic ColonizationBrain Metastatic NicheMetastatic Her2-positive Breast CancerMetastatic SignalingNeurotrophic Factor SignalingNeurotrophin Receptor SignalingTrkb Signaling
BACKGROUND: Patients with primary breast cancer that is positive for human epidermal growth factor receptor 2 (Her2+) have a high risk of developing metastases in the brain. Despite gains with systemic control of Her2+ disease using molecular therapies, brain metastases remain recalcitrant to therapeutic discovery. The clinical predilection of Her2+ breast cancer cells to colonize the brain likely relies on paracrine mechanisms. The neural niche poses unique selection pressures, and neoplastic cells that utilize the brain microenvironment may have a survival advantage. METHODS: Tropomyosin-related kinase B (TrkB), Her2, and downstream targets were analyzed in primary breast cancer, breast-to-brain metastasis (BBM) tissues, and tumor-derived cell lines using quantitative real-time PCR, western blot, and immunohistochemical assessment. TrkB function on BBM was confirmed with intracranial, intracardiac, or mammary fat pad xenografts in non-obese diabetic/severe combined immunodeficiency mice. The function of brain-derived neurotrophic factor (BDNF) on cell proliferation and TrkB/Her2 signaling and interactions were confirmed using selective shRNA knockdown and selective inhibitors. The physical interaction of Her2-TrkB was analyzed using electron microscopy, co-immunoprecipitation, and in silico analysis. Dual targeting of Her2 and TrkB was analyzed using clinically utilized treatments. RESULTS: We observed that patient tissues and cell lines derived from Her2+ human BBM displayed increased activation of TrkB, a neurotrophin receptor. BDNF, an extracellular neurotrophin, with roles in neuronal maturation and homeostasis, specifically binds to TrkB. TrkB knockdown in breast cancer cells led to decreased frequency and growth of brain metastasis in animal models, suggesting that circulating breast cancer cells entering the brain may take advantage of paracrine BDNF-TrkB signaling for colonization. In addition, we investigated a possible interaction between TrkB and Her2 receptors on brain metastatic breast cancer cells, and found that BDNF phosphorylated both its cognate TrkB receptor and the Her2 receptor in brain metastatic breast cancer cells. CONCLUSION: Collectively, our findings suggest that heterodimerization of Her2 and TrkB receptors gives breast cancer cells a survival advantage in the brain and that dual inhibition of these receptors may hold therapeutic potential.
25
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Genes that mediate breast cancer metastasis to lung
Andy J. Minn, Gaorav P. Gupta, Peter M. Siegel et al. · Nature · 2005 · 3K citations · Full text
Genomic Analysis of Reactive Astrogliosis
Jennifer Zamanian, Lijun Xu, Lynette C. Foo et al. · Journal of Neuroscience · 2012 · 2.5K citations · Full text
Medicine, Neurobiology, Neuroscience +17
Metastatic Behavior of Breast Cancer Subtypes
Hagen F. Kennecke, Rinat Yerushalmi, Ryan Woods et al. · Journal of Clinical Oncology · 2010 · 2.3K citations · Full text
Medicine, Cancer Biology, Oncology +14
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Lin Zhang, Siyuan Zhang, Jun Yao et al. · Nature · 2015 · 1.2K citations · Full text